Therapeutic Asset Ratings

435 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Panobinostat Non-Hodgkin Lymphoma	OHSU Knight Cancer Institute	P2	B (58)
POLO-LIKE KINASE 1 INHIBITOR NMS-1286937 Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	P2	B (58)
Regorafenib Breast Cancer	OHSU Knight Cancer Institute	P2	B (58)
TRASTUZUMAB Refractory Malignant Neoplasm	OHSU Knight Cancer Institute	P2	B (58)
Trastuzumab Emtansine Recurrent Ovarian Carcinoma	OHSU Knight Cancer Institute	P2	B (58)
Trastuzumab Emtansine Refractory Malignant Neoplasm	OHSU Knight Cancer Institute	P2	B (58)
VEMURAFENIB Advanced Malignant Solid Neoplasm	OHSU Knight Cancer Institute	P2	B (58)
VEMURAFENIB Anatomic Stage IV Breast Cancer AJCC v8	OHSU Knight Cancer Institute	P2	B (58)
VEMURAFENIB Refractory Malignant Neoplasm	OHSU Knight Cancer Institute	P2	B (58)
Dfn-15 Prostate Cancer	OHSU Knight Cancer Institute	P2/3	B (58)
Dabrafenib Non-Hodgkin Lymphoma	OHSU Knight Cancer Institute	P2	B (57)
Dabrafenib Breast Carcinoma	OHSU Knight Cancer Institute	P2	B (57)
Dabrafenib Refractory Malignant Neoplasm	OHSU Knight Cancer Institute	P2	B (57)
Dasatinib B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1	OHSU Knight Cancer Institute	P2	B (57)
Dasatinib Breast Carcinoma	OHSU Knight Cancer Institute	P2	B (57)
Dasatinib Refractory Malignant Neoplasm	OHSU Knight Cancer Institute	P2	B (57)
Ipilimumab Chronic Myelomonocytic Leukemia	OHSU Knight Cancer Institute	P2	B (57)
Ipilimumab Myelodysplastic Syndrome	OHSU Knight Cancer Institute	P2	B (57)
su011248 Prostate Cancer	OHSU Knight Cancer Institute	P2	B (57)
TAMOXIFEN Sarcoma	OHSU Knight Cancer Institute	P2	B (57)
Vorinostat Chronic Myelomonocytic Leukemia	OHSU Knight Cancer Institute	P2	B (57)
Vorinostat Myelodysplastic Syndrome	OHSU Knight Cancer Institute	P2	B (57)
Capecitabine Soft Tissue Sarcoma	OHSU Knight Cancer Institute	P1/2	B (57)
Gdc-0449 Soft Tissue Sarcoma	OHSU Knight Cancer Institute	P1/2	B (57)
Vinorelbine Sarcoma	OHSU Knight Cancer Institute	P1/2	B (57)

Showing 176 to 200 of 435 assets

PreviousPage 8 of 18Next